TruTrace Technologies Inc. Share Price
Equities
TTT
CA8984471075
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Sales 2021 | 0.16 0.22 13.54 | Sales 2022 | 0.12 0.16 9.87 | Capitalization | 3.82M 5.21M 318M |
---|---|---|---|---|---|
Net income 2021 | -1M -1.37M -83.32M | Net income 2022 | -2M -2.73M -167M | EV / Sales 2021 | 8,37,73,009 x |
Net cash position 2021 | 893K 1.22M 74.39M | Net Debt 2022 | 681K 930K 56.74M | EV / Sales 2022 | 3,79,73,468 x |
P/E ratio 2021 |
-6.71
x | P/E ratio 2022 |
-1.64
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.1% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11/11/11 | |
Robert Lelovic
DFI | Director of Finance/CFO | - | 16/21/16 |
James LaValle
CTO | Chief Tech/Sci/R&D Officer | - | 21/19/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cesare Fazari
BRD | Director/Board Member | - | 09/20/09 |
Robert Galarza
BRD | Director/Board Member | 45 | 17/18/17 |
Allan O'Dette
CHM | Chairman | - | 06/20/06 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 555K | |
+4.63% | 32.15B | |
+18.74% | 7.41B | |
+20.94% | 3.85B | |
-17.01% | 3.13B | |
-22.16% | 1.25B | |
-31.01% | 1.17B | |
+4.40% | 926M | |
-34.81% | 911M | |
-25.64% | 842M |
- Stock Market
- Equities
- TTT Stock